Immunohistochemical evaluation of phosphorylated SMAD2/SMAD3 and the co-activator P300 in human glomerulonephritis: correlation with renal injury

被引:11
作者
Kassimatis, Theodoros I. [1 ]
Giannopoulou, Ioanna
Koumoundourou, Dimitra
Theodorakopoulou, Emily
Varakis, Ioannis
Nakopoulou, Lydia
机构
[1] Evangelismos Gen Hosp, Dept Nephrol, Athens, Greece
[2] Univ Patras, Dept Anat Histol & Embryol, Sch Med, Patras, Greece
[3] Atticon Univ Hosp, Dept Pathol 2, Athens, Greece
[4] Patras Univ Hosp, Div Internal Med, Patras, Greece
关键词
glomerulonephritis; pSmad2/3; p300; renal fibrosis;
D O I
10.2755/jcmm010.004.05
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Background: Smad2 and Smad3 are transcription factors that mediate transforming growth factor beta (TGF-beta) signals. Upon their activation, phosphorylated Smad2/Smad3 (pSmad2/Smad3), translocate to the nucleus and associate with co-activators such as p300, regulating the transcription of genes that contribute to the fibrotic processes. Methods: We investigated the immunohistochemical expression of pSmad2/Smad3 and the co-activator p300 in 152 renal biopsy specimens from patients with various types of glomerulonephritides (GNs) and in 15 normal kidney specimens. Patients' clinical data (serum creatinine levels and proteinuria) had been collected. Results: There was a dramatic increase in the expression of pSmad2/3 and p300 in all glomerular cell types in all GNs. pSmad2/3 expression was increased in all tubular segments (except for the proximal tubules in nonproliferative GNs), while p300 expression was significantly increased only in the proximal tubular cells in all GNs. Glomerular and tubular pSmad2/Smad3 and p300 were significantly increased in proliferative GNs (compared to the nonproliferative), particularly in the secondary group. The expression profile of p300 correlated positively with the expression of pSmad2/Smad3 in the diseased glomeruli and proximal tubules. pSmad2/3 and p300 were very often detected in segmental hyperplastic lesions, cellular crescents, microadhesions and segmental or global sclerotic areas. Glomerular and proximal tubular pSmad2/Smad3 was positively correlated with serum creatinine levels, while distal and collecting tubular pSmad2/3 and p300 correlated positively with tubular atrophy. Glomerular and proximal tubular pSmad2/3 expression and glomerular p300 expression correlated positively with lupus nephritis activity. Conclusion: Our results suggest that pSmad2/3-p300 pathway may play a pivotal role in the pathogenesis and progression of human glomerulonephritis.
引用
收藏
页码:908 / 921
页数:14
相关论文
共 52 条
[1]   Localization of TGF-β and its receptors in the kidney [J].
Ando, T ;
Okuda, S ;
Yanagida, T ;
Fujishima, M .
MINERAL AND ELECTROLYTE METABOLISM, 1998, 24 (2-3) :149-153
[2]  
[Anonymous], 1991, PEPTIDE GROWTH FACTO
[3]   Fibroblast expression of the coactivator p300 governs the intensity of profibrotic response to transforming growth factor β [J].
Bhattacharyya, S ;
Ghosh, AK ;
Pannu, J ;
Mori, Y ;
Takagawa, S ;
Chen, GF ;
Trojanowska, M ;
Gilliam, AC ;
Varga, J .
ARTHRITIS AND RHEUMATISM, 2005, 52 (04) :1248-1258
[4]   Mechanisms of disease:: Role of transforming growth factor β in human disease. [J].
Blobe, GC ;
Schiemann, WP ;
Lodish, HF .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (18) :1350-1358
[5]   TGF-beta in kidney fibrosis: A target for gene therapy [J].
Border, WA ;
Noble, NA .
KIDNEY INTERNATIONAL, 1997, 51 (05) :1388-1396
[6]   TGF-β signaling in renal disease [J].
Böttinger, EP ;
Bitzer, M .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 (10) :2600-2610
[7]   Retrieved endogenous biotin: a novel marker and a potential pitfall in diagnostic immunohistochemistry [J].
Bussolati, G ;
Gugliotta, P ;
Volante, M ;
Pace, M ;
Papotti, M .
HISTOPATHOLOGY, 1997, 31 (05) :400-407
[8]   Role of transforming growth factor-β signaling in cancer [J].
de Caestecker, MP ;
Piek, E ;
Roberts, AB .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2000, 92 (17) :1388-1402
[9]   The Smad4 activation domain (SAD) is a proline-rich, p300-dependent transcriptional activation domain [J].
de Caestecker, MP ;
Yahata, T ;
Wang, D ;
Parks, WT ;
Huang, SX ;
Hill, CS ;
Shioda, T ;
Roberts, AB ;
Lechleider, RJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (03) :2115-2122
[10]  
Debes JD, 2003, CANCER RES, V63, P7638